Pharmacogenomics Advisory Committee Being Formed By FDA To Oversee Data Submissions

The agency expects to publish final pharmacogenomics guidance this summer, along with "companion documents" on the interdisciplinary PG review group and a standard process for voluntary PG data submissions, FDA's Lesko tells DIA EuroMeeting in Prague.